Victory Square Reports Q1 2026 Financial Results and Provides Portfolio Update

Q1 2026 Revenue

$24.9 Million

Total revenue reported for the first quarter of 2026.

Net Income

$3.9 Million

Net income for the first quarter of 2026.

Cash & Marketable Securities

$31 Million

Total cash and marketable securities as of March 31, 2026.

§ 01 Executive Snapshot

What: Victory Square Technologies Inc. reports Q1 2026 financial results showing significant growth in revenue and net income.
Who: Victory Square Technologies Inc. (VST), Hydreight Technologies, Insu Therapeutics, Pawsible Ventures.
Why it matters: The report highlights Victory Square's transition from a venture builder to a platform owner, showcasing its strategic growth in healthcare and technology sectors.

Revenue increased to $24.9 million, compared to $4.5 million in Q1 2025.
Gross profit increased to $5.1 million, compared to $1.5 million in the prior-year period.
Net income totaled approximately $3.9 million.
Cash & marketable securities increased to approximately $31 million at March 31, 2026.
Completion of a $15 million financing by Hydreight Technologies.

Victory Square is evolving from a venture builder to a platform owner, focusing on healthcare technologies and infrastructure.
The company is strategically positioned in rapidly growing markets, including digital health and AI, which are expected to see significant innovation and investment.

Immediate consequences include strengthened financial flexibility and enhanced operational capabilities across portfolio companies.
Long-term implications involve potential market leadership in healthcare solutions and technology platforms, driven by strategic investments and partnerships.

Regulatory changes could impact operational strategies and market entry for portfolio companies.
Execution risks at the portfolio company level may affect overall performance and financial outcomes.

Upcoming developments include advancing Insu Therapeutics’ delivery platform and expanding Pawsible Ventures’ initiatives in pet health.
The scheduled webinar on June 9, 2026, will provide further insights into the company’s strategic direction and financial performance.

§ 07

What were Victory Square's financial results for Q1 2026?

Victory Square reported revenue of $24.9 million and a net income of approximately $3.9 million for Q1 2026.

Why is Victory Square's transition to a platform owner significant?

This transition highlights their strategic growth in healthcare and technology sectors, positioning them for potential market leadership.

How much cash and marketable securities did Victory Square have by March 31, 2026?

Victory Square had approximately $31 million in cash and marketable securities as of March 31, 2026.